Neuro-Endocrine Effects of Opioids
Advances in Alcohol & Substance Abuse · 1982
DOI: 10.1300/j251v01n01_06 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Alcohol & Substance Abuse, 1982. Verfasst von Paul Cushman. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
A catalogue of human endocrine effects of opioid agonists are reported. These effects are usually attenuated by opioid antogonists. Acute agonists may increase prolactin and decrease LH and testosterone. They may have opposity effects on GH. FSH, TSH. Increased catecholamines, and glucagon may account for opioid-induced hyperglycemia. Opioid antagonists alone may increase LH and less consistenly ACTH/cortisol and decrease prolactin. Opioid-tolerant persons usually show at least partial tolerance to these changes in LH, prolactin, and testosterone. The increase in thyroxine and thyroid binding globulin observed in heroin addicts may relate to relative hypoandorogenicity or liver disease rather than to hyperthyrodism. Disturbed sexual appetite and performance obersrver in men and women may relate to hormonal changes, or other facets of opiate use or may be symptoms of underlying psychological disorders.
Zitieren
APA
Cushman, P. (1982). Neuro-Endocrine Effects of Opioids. Advances in Alcohol & Substance Abuse. https://doi.org/10.1300/j251v01n01_06
Vancouver
Cushman P. Neuro-Endocrine Effects of Opioids. Advances in Alcohol & Substance Abuse. 1982. doi:10.1300/j251v01n01_06
BibTeX
@article{Cushman1982,
author = {Cushman, Paul},
title = {Neuro-Endocrine Effects of Opioids},
journal = {Advances in Alcohol & Substance Abuse},
year = {1982},
doi = {10.1300/j251v01n01_06}
}
EUVIMED